InvestorsHub Logo

DaubersUP

08/08/20 2:29 AM

#317862 RE: cybermich #317861

I think there is a major difference from a drug dosing 400 plus in clinical trials and a drug approved for the past 30 years. We will see a phase 2 imo. Small and quick trial is my guess. But, I’m wrong often.

attilathehunt

08/08/20 8:30 AM

#317875 RE: cybermich #317861

I think we will start off with a phase2 and when early results come in, we can jump to EUA.


I wonder how long does it take for B to do it's job? How many days before they see results (i.e. viral load does 50%, patients are removed from ventilators, they get to go home, etc.).

Let's assume 5 days. I would venture to guess we would see EUA within 30 days of the start of phase2.

Once trial starts is when we will our share price no longer bound to gravity ($1B MC) and upon EUA ($3-5B MC) and then possible buyout after 1st of year.

zandant

08/08/20 11:28 AM

#317888 RE: cybermich #317861

Some insight into their confidence level and anticipated timeline.

https://www.reuters.com/article/us-health-coronavirus-relief-hldg/relief-therapeutics-sees-60-70-chance-of-covid-19-drug-approval-idUSKCN25409K

IPIX at first glance appears to be a better company overall. Yet, that group is surging ahead. Is their product really that good? As with everything, time will tell.